Medication info
Rozduo Tablets 10/5 mg

Rozduo Tablets 10/5 mg

Prescription medicationTabletOral
Ingredient · strength
Rosuvastatin Calcium Micronized›5.2mg / 1 tabletEzetimibe›10mg / 1 tablet
Manufacturer / importer
Jeil Pharmaceutical Co., Ltd.
Appearance
Pink oblong film-coated tablets
Packaging
30 tablets/box [(10 tablets/PTPX3)], 30 tablets/bottle
Approval status
Active

MFDS item code 201506794 · Approved 2015.09.24 · Insurance code 645404550

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
Administer this medicine once daily, regardless of meals. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range for this medicine is 10/5mg~10/20mg daily. The recommended initial dose is 10/5mg daily. The dose may be adjusted for patients requiring a greater reduction in LDL cholesterol. After starting treatment or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly; the dose may be increased to a maximum of 10/20mg daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience.

Ingredients

Manufacturer
Jeil Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL-cholesterol
  • elevated Apo B protein
  • elevated triglycerides
  • elevated non-HDL cholesterol
  • increased risk of atherogenic vascular disease due to hypercholesterolemia
View approved original text

This medicine helps lower elevated total cholesterol, LDL-cholesterol, Apo B, triglycerides, and non-HDL cholesterol levels, and helps raise HDL cholesterol levels in patients with primary hypercholesterolemia, particularly heterozygous familial and non-familial hypercholesterolemia or mixed dyslipidemia. It is used in conjunction with an appropriate diet, as an adjunct when dietary control alone is insufficient. Furthermore, it is prescribed for patients at high risk of atherogenic vascular disease due to hypercholesterolemia after adequately considering risk factors. Before use, it is important to check for dyslipidemia caused by other diseases or medications, and if a secondary cause is present, it should be treated first. During treatment, lipid levels such as total cholesterol, LDL, HDL, and triglycerides should be monitored, and if necessary, precise tests using ultracentrifugation should be performed. This drug helps improve vessel health through management of dyslipidemia.

How to take

Adult dose

Administer this medicine once daily, regardless of meals. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range for this medicine is 10/5mg~10/20mg daily. The recommended initial dose is 10/5mg daily. The dose may be adjusted for patients requiring a greater reduction in LDL cholesterol. After starting treatment or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly; the dose may be increased to a maximum of 10/20mg daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience.

Precautions

This drug has a rare risk of inducing rhabdomyolysis, which can lead to severe muscle damage and acute renal failure. Therefore, if severe muscle pain or weakness occurs, the physician should be notified immediately. In cases with certain risk factors, the administration of this drug should be temporarily suspended or discontinued. This drug should not be used by patients with allergies to the ingredients, liver disease, severe renal failure, or muscle disorders, and by women who are pregnant or nursing. Furthermore, it should be used cautiously in patients with decreased renal function, hypothyroidism, a family history of muscle disorders, alcohol dependence, and in those taking certain medications. Regular liver function and muscle-related tests should be conducted during administration, and if there is a significant increase in liver enzymes or severe muscle pain, treatment should be stopped immediately. Rarely, side effects such as headaches, dyspepsia, edema, myalgia may occur, and serious adverse reactions such as severe skin reactions, liver damage, or myasthenia gravis can occur. Women during pregnancy or those who may become pregnant should ensure appropriate contraception and should discontinue use immediately if pregnancy is confirmed. Special care is needed for the elderly and pediatric patients, as safety in children has not been established and is not recommended. This drug may interact with other medications; therefore, patients should inform their healthcare provider of any medications they are taking, and coagulation status should be periodically monitored if administered with anticoagulants such as warfarin. There is no specific antidote for overdose, so appropriate treatment should be provided based on symptoms, and liver function and muscle enzyme levels should be monitored. Lastly, keep this medicine out of reach of children and do not transfer it to another container.

Side effects

nasopharyngitis, dyspepsia, elevation of ALT, edema, myalgia, headache, acute pyelonephritis, dry mouth, elevation of liver enzymes, abnormal liver function tests, increased serum lactate dehydrogenase, pruritus, upper respiratory infection, elevated blood glucose, increased serum CPK, chest discomfort, dizziness, drowsiness, neurodegenerative disorders, positional dizziness, migraine, diabetes mellitus, glucose tolerance disorder, depression, bronchitis, rhinitis, cystitis, onychomycosis, soft tissue inflammation, hepatic steatosis, liver impairment, hepatic toxicity, acute hepatitis, toxic hepatitis, increased gamma-glutamyl transferase, elevated blood cholesterol, increased serum alkaline phosphatase, arrhythmia, osteoarthritis, osteoporosis, musculoskeletal stiffness, musculoskeletal discomfort, muscle weakness, diaphoresis, dermatitis, skin burning sensation, skin disorders, alopecia, oropharyngeal pain, nasal obstruction, respiratory distress, pelvic pain, breast cysts, ptosis, diabetic retinopathy, ear discomfort, renal dysfunction, benign esophageal neoplasm, vascular edema, angioedema, hypersensitivity reactions, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myopathy, myositis, rhabdomyolysis, asthenia, thrombocytopenia, jaundice, hepatitis, Stevens-Johnson syndrome, eosinophilia with systemic symptoms drug reaction syndrome, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, sleep disorders, insomnia, nightmares, interstitial lung disease, sexual dysfunction, gynecomastia, fatal liver failure, non-fatal liver failure, cognitive impairment, memory decline, forgetfulness, amnesia, memory disorders, confusion, severe muscle weakness, ocular myasthenia, fatigue, chest pain, chest discomfort, systemic edema, diabetic neuropathy, trembling, epigastric pain, vomiting, gastritis, xerostomia, epigastric discomfort, belching, gastrointestinal disorders, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, cough, sputum, rhinorrhea, limb pain, arthralgia, hypoglycemia, anemia, splenomegaly, urticaria, hyperhidrosis, conjunctival injection, renal failure, abnormal liver function, increased serum creatinine, elevated blood pressure, increased urea, muscle cramps, gout, erectile dysfunction, syncope, widespread pain

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine may be sensitive to air or moisture, so it must be stored in a tightly closed container. It is recommended to maintain a storage temperature between 1 degree and 30 degrees Celsius in a cool, dry place. This way, the efficacy and safety of the drug can be well preserved.

Appearance and packaging

Appearance

Pink oblong film-coated tablets

Package unit

30 tablets/box [(10 tablets/PTPX3)], 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.